Berry G - Search Results

1

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

Safra T, Muggia F, Jeffers S, Tsao-Wei DD, Groshen S, Lyass O, Henderson R, Berry G, Gabizon A. Safra T, et al. Among authors: berry g. Ann Oncol. 2000 Aug;11(8):1029-33. doi: 10.1023/a:1008365716693. Ann Oncol. 2000. PMID: 11038041 Free article.

2

Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignancies.

Gabizon AA, Lyass O, Berry GJ, Wildgust M. Gabizon AA, et al. Cancer Invest. 2004;22(5):663-9. doi: 10.1081/cnv-200032899. Cancer Invest. 2004. PMID: 15581046 Clinical Trial.

3

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin.

Berry G, Billingham M, Alderman E, Richardson P, Torti F, Lum B, Patek A, Martin FJ. Berry G, et al. Ann Oncol. 1998 Jul;9(7):711-6. doi: 10.1023/a:1008216430806. Ann Oncol. 1998. PMID: 9739435 Free article.

4

Pathology of radiation and anthracycline cardiotoxicity.

Berry GJ, Jorden M. Berry GJ, et al. Pediatr Blood Cancer. 2005 Jun 15;44(7):630-7. doi: 10.1002/pbc.20346. Pediatr Blood Cancer. 2005. PMID: 15825155 Review.

5

Lymphocytic myocarditis after lung transplantation.

Weinkauf J, Walia R, Berry GJ, Vagelos R, Faul JL. Weinkauf J, et al. J Heart Lung Transplant. 2005 Aug;24(8):1163-5. doi: 10.1016/j.healun.2004.07.012. J Heart Lung Transplant. 2005. PMID: 16102466

6

Clinical and pathological absence of cardiotoxicity after liposomal doxorubicin.

Jones RL, Berry GJ, Rubens RD, Miles DW. Jones RL, et al. Lancet Oncol. 2004 Sep;5(9):575-7. doi: 10.1016/S1470-2045(04)01570-0. Lancet Oncol. 2004. PMID: 15337488 No abstract available.

7

Giant cell myocarditis.

Cooper LT Jr, Berry GJ, Rizeq M, Schroeder JS. Cooper LT Jr, et al. Among authors: berry gj. J Heart Lung Transplant. 1995 Mar-Apr;14(2):394-401. J Heart Lung Transplant. 1995. PMID: 7779862

8

Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A; Consensus Conference Participants. Kobashigawa J, et al. Among authors: berry g. J Heart Lung Transplant. 2011 Mar;30(3):252-69. doi: 10.1016/j.healun.2010.11.003. J Heart Lung Transplant. 2011. PMID: 21300295 Free PMC article.

9

Heart-lung transplantation: Cardiac clinicopathological correlations.

Joshi A, Oyer PE, Berry GJ, Billingham ME. Joshi A, et al. Among authors: berry gj. Cardiovasc Pathol. 1996 May-Jun;5(3):153-8. doi: 10.1016/1054-8807(95)00114-x. Cardiovasc Pathol. 1996. PMID: 25851477 Free article.

10

Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection.

Haddad F, Fisher P, Pham M, Berry G, Weisshaar D, Kuppahally S, Vrtovec B, Deuse T, Virani S, Fearon W, Valantine H, Hunt S. Haddad F, et al. Among authors: berry g. J Heart Lung Transplant. 2009 Apr;28(4):312-9. doi: 10.1016/j.healun.2008.12.023. J Heart Lung Transplant. 2009. PMID: 19332256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,101 results

Search Page

Filters